Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer

Documenti analoghi

• Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer
  di: Sasako, Mitsuru, et al.
  Pubblicazione: (2014)
• Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer
  di: Ichikawa, Wataru, et al.
  Pubblicazione: (2016)
• TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study
  di: Terashima, Masanori, et al.
  Pubblicazione: (2017)
• Quantitative Measurement of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Level in Gastric Cancer by Real‐time RT‐PCR
  di: Fujiwara, Hisataka, et al.
  Pubblicazione: (2002)
• Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression
  di: Kruhøffer Mogens, et al.
  Pubblicazione: (2009-01-01)